35
Views
11
CrossRef citations to date
0
Altmetric
Original Articles

Impact of the 2004 mass drug administration for the control of lymphatic filariasis, in urban and rural areas of the Western province of Sri Lanka

, , &
Pages 335-341 | Published online: 18 Jul 2013

References

  • Ismail, M. M., Jayakody, R. L., Weil, G. J., Fernando, D., de Silva, M. S. G., de Silva, G. A. C. & Balasooriya, W. K. (2001). Long term efficacy of single-dose combinations of albendazole, ivermectin and diethylcarbamazine for the treatment of ban-croftian filariasis. Transactions of the Royal Society of Tropical Medicine and Hygiene, 95, 332–335.
  • Ramaiah, K. D. & Das, P. K. (2004). Mass drug administration to eliminate lymphatic filariasis in India. Trends in Parasitology, 20, 499-502
  • Ramaiah, K. D., Vanarnail, P., Pani, S. P., Yuvaraj, J. & Das, P. K. (2002). The effect of six rounds of single dose mass treatment with diethylcarbamazine or ivermectin on Wuchereria bancrofti infection and its implications for lymphatic filariasis elimination. Tropical Medicine and International Health, 7, 767–774
  • Washington, C. H., Radday, J., Streit, T. G., Boyd, H. A., Beach, M. J., Addiss, D. G., Lovince, R., Lovegrove, M. C., Lafontant, J. G., Lammie, P. J. & Hightower, A. W. (2004). Spatial clustering of filarial transmission before and after a mass drug administration in a setting of low infection preva-lence. Filaria Journal, 3, 3.
  • World Health Organization (1984). Lymphatic Filariasis. Fourth Report of the WHO Expert Committee on Filariasis. Techinical Report Series No. 702. Geneva: WHO.
  • World Health Organization (2003). Annual Report on Lymphatic Filariasis 2002. Document WHO/CDS/ CPE/CEE/2003.38. Geneva: WHO.
  • World Health Organization (2005a). Monitoring and Epidemiological Assessment of the Programme to Eliminate Lymphatic Filariasis at Implementation Unit Level. Document WHO/CDS/CPE/CEE/2005.50. Geneva: WHO.
  • World Health Organization (2005b). Annual Report on Lymphatic Filariasis 2003. Document WHO/CDS/ CPE/CEE/2005.52. Geneva: WHO.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.